-
Haɓaka Tsarin Ci gaban Magunguna
Gabaɗaya Bayanin Bioantibody na farko-a-aji da mafi kyawun fayil an ƙera shi don magance manyan buƙatun likitanci waɗanda ba a cika su ba ta hanyar haɓaka nau'ikan ƙwayoyin cuta guda biyu da takamaiman furotin, magungunan rigakafin ƙwayoyin cuta da macrophage masu haɓakawa ga marasa lafiya a duk duniya.Tarihi Binciken da Kohler da Milstein da Kohler da Milstein suka yi na fasahar rigakafin ƙwayar cuta ta monoclonal (mAb) a cikin 1975 ya ba da damar ƙirƙirar ƙwayoyin rigakafi a matsayin nau'in warkewa (Kohler & Milste ...
